뉴어액시스 (NRXS) 주가

뉴어액시스(NRXS)는 AMX에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $7.61 (-0.26%), 시가총액 $92.02M, 52주 범위 $2.29 ~ $8.81.

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics.

핵심 지표

• 현재가: $7.61 (-0.26%)
• 시가총액: $92.02M
• 52주 최저~최고: $2.29 ~ $8.81
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: AMX

뉴어액시스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

뉴어액시스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 적극 매수 (5.0 / 5)

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 16.02
• 순이익률: -170.11%
• 영업이익률: -108.26%

자주 묻는 질문